Michael Singer

ORCID: 0000-0002-0149-4802 · 2 papers in corpus
article 2016
letter 2016
·doi:10.1111/aos.13318

Although intra-ocular antivascular endothelial growth factor (VEGF) injections are the standard of care for patients with diabetic macular oedema (DME), some fail this treatment. This begets the need for alternative therapies for these pati…